Lidocaine HCl

API Local Anesthetic Chemical Lidocaine HCl Base Powder CAS 137-58-6

 

  • Aha ngwaahịa:

    Lidocaine HCl

  • Ọkwa:

    Ọkwa ọgwụ

  • Njirimara:

    ọcha ntụ ntụ

  • Nkwakọ ngwaahịa:

    25kg / agba

  • MOQ:

    1 kilo

  • Nchekwa:Ebe dị jụụ
  • Ndụ nchekwa:afọ 2


Nkọwa

Tags

Nkọwa ngwaahịa

Lidocaine hydrochloride is metabolized rapidly by the liver, and metabolites and unchanged drug are excreted by the kidneys. Biotransformation includes oxidative N-dealkylation, ring hydroxylation, cleavage of the amide linkage, and conjugation. N-dealkylation, a major pathway of biotransformation, yields the metabolites monoethylglycinexylidide and glycinexylidide. The pharmacological/toxicological actions of these metabolites are similar to, but less potent than, those of Lidocaine hydrochloride. Approximately 90% of Lidocaine hydrochloride administered is excreted in the form of various metabolites, and less than 10% is excreted unchanged. The primary metabolite in urine is a conjugate of 4-hydroxy-2,6-dimethylaniline.

<trp-post-container data-trp-post-id='11756'>Lidocaine HCl</trp-post-container><trp-post-container data-trp-post-id='11756'>Lidocaine HCl</trp-post-container><trp-post-container data-trp-post-id='11756'>Lidocaine HCl</trp-post-container><trp-post-container data-trp-post-id='11756'>Lidocaine HCl</trp-post-container>
Ngwa

1. Lidocaine, xylocaine, or lignocaine is a common local anesthetic and class-1b antiarrhythmic drug. Lidocaine is used topically to relieve itching, burning, and pain from skin inflammations, injected as a dental anesthetic, or as a local anesthetic for minor surgery.
 2.It is on the World Health Organization's List of Essential Medicines, a list of the most important medications needed in a basic healthcare system.
 3. Lidocaine is the most important class-1b antiarrhythmic drug; it is used intravenously for the treatment of ventricular arrhythmias if amiodarone is not available or contraindicated.
 4. Lidocaine should be given for this indication after defibrillation, CPR, and vasopressors have been initiated. A routine prophylactic administration is no longer recommended for acute cardiac infarction; the overall benefit of this measure is not convincing.

Uru

Anyị nwere ọtụtụ ụlọ ọrụ dị elu nke nwere nkwado miri emi, nke nwere ike inye gị ngwaahịa dị elu na ọnụ ahịa asọmpi. Anyị nwekwara ike inye ego maka nnukwu ịzụrụ ihe. Anyị na-akwado ọtụtụ ụlọ ọrụ na-ebuga ibu ndị ọkachamara, nwere ike ịnapụta ngwaahịa n'enweghị nsogbu na aka gị. Oge nnyefe bụ ihe dịka ụbọchị 3-20 mgbe nkwenye nke ịkwụ ụgwọ gasịrị.

<trp-post-container data-trp-post-id='11756'>Lidocaine HCl</trp-post-container><trp-post-container data-trp-post-id='11756'>Lidocaine HCl</trp-post-container><trp-post-container data-trp-post-id='11756'>Lidocaine HCl</trp-post-container><trp-post-container data-trp-post-id='11756'>Lidocaine HCl</trp-post-container>

 

Nkọwapụta

<trp-post-container data-trp-post-id='11756'>Lidocaine HCl</trp-post-container>

 

Mbupu na ịkwụ ụgwọ

<trp-post-container data-trp-post-id='11756'>Lidocaine HCl</trp-post-container>

 

FAQ

1. Ị bụ ụlọ ọrụ mmepụta ihe ma ọ bụ ụlọ ọrụ ịzụ ahịa?
Anyị bụ ụlọ ọrụ na-ejikọta ụlọ ọrụ na ịzụ ahịa, na-enye ọrụ nkwụsịtụ.OEM nwere ike ịnakwere.

2. Ị na-enye samples? Ọ bụ n'efu ka ọ bụ mgbakwunye?
Free samples. The sample si ibu ego kwesịrị ịkwụ ụgwọ gị n'akụkụ.

3. Ị nwere asambodo ọ bụla metụtara njikwa mma?
ISO 9001: 2008 asambodo iji hụ na ịdị mma.

4. Kedu ihe m ga-enye ka m nweta nhota okwu?
Pls na-agwa anyị ụdị ngwaahịa nke ị chọrọ, iji ọnụ ọgụgụ, adreesị na ihe ndị a chọrọ. A ga-edepụta nkwupụta maka ntinye aka gị n'oge.

5. Kedu ụdị usoro ịkwụ ụgwọ na-amasị gị? Kedu ụdị usoro anabatara?
Usoro nnyefe anabatara: FOB, CFR, CIF, EXW;
Accepted Payment Currency:USD;EUR
Ụdị ịkwụ ụgwọ anabatara: T/T, Western Union; Paypal, ahia ahia.
Asụsụ Asụsụ: Bekee.

 

Ọ bụrụ na ị nwere mmasị na ngwaahịa anyị, ị nwere ike ịhọrọ ịhapụ ozi gị ebe a, anyị ga-akpọtụrụ gị n'oge na-adịghị anya.


Dee ozi gị ebe a ziga anyị ya